Valley National Advisers Inc Axonics, Inc. Transaction History

Valley National Advisers Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$66.47 - $69.65 $332 - $348	-5 Reduced 5.56%	85 $5,000
Q1 2024 Apr 19, 2024	BUY	$56.67 - $69.36 $283 - $346	5 Added 5.88%	90 $6,000
Q4 2023 Jan 25, 2024	BUY	$49.38 - $63.75 $3,456 - $4,462	70 Added 466.67%	85 $5,000
Q3 2023 Nov 13, 2023	BUY	$48.64 - $62.51 $729 - $937	15 New	15 $1,000

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Valley National Advisers Inc with notifications on news.